WHO Classification of Tumours Editorial Board. Endocrine and neuroendocrine tumours [Internet; beta version ahead of print]. Lyon (France): International Agency for Research on Cancer; 2022 [cited 2023–05–02]. (WHO classification of tumours series, 5th ed.; vol. 10). Available from: https://tumourclassification.iarc.who.int/chapters/53.

Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, LiVolsi VA, Papotti MG, Sobrinho-Simoes M, Tallini G, Mete O Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocr Pathol 2022 Mar;33(1):27-63.

Article  PubMed  Google Scholar 

Lloyd RYO, Klöppel G, Rosai J WHO Classification of Tumours of Endocrine Organs. (IARC, 2017) (4th ed).

Boyraz B, Sadow PM, Asa SL, Dias-Santagata D, Nose V, Mete O. Cribriform-Morular Thyroid Carcinoma Is a Distinct Thyroid Malignancy of Uncertain Cytogenesis. Endocr Pathol 2021 Sep;32(3):327-335.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hirokawa M, Maekawa M, Kuma S, Miyauchi A Cribriform-morular variant of papillary thyroid carcinoma-Cytological and immunocytochemical findings of 18 cases. Diagn Cytopathol, 2010 Dec;38(12):890-6.

Article  PubMed  Google Scholar 

Tomoda C, Miyauchi A, Uruno T, Takamura Y, Ito Y, Miya A, Kobayashi K, Matsuzuka F, Kuma S, Kuma K, Kakudo K Cribriform-morular variant of papillary thyroid carcinoma: clue to early detection of familial adenomatous polyposis-associated colon cancer. World J Surg 2004 Sep;28(9):886-9.

Article  PubMed  Google Scholar 

Lam A K, Saremi N Cribriform-morular variant of papillary thyroid carcinoma: a distinctive type of thyroid cancer. Endocr Relat Cancer 2017 Apr;24(4):R109-R121.

Article  CAS  PubMed  Google Scholar 

Akaishi J, Kondo T, Sugino K, Ogimi Y, Masaki C, Hames KY, Yabuta T, Tomoda C, Suzuki A, Matsuzu K, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Katoh R, Ito K Cribriform-Morular Variant of Papillary Thyroid Carcinoma: Clinical and Pathological Features of 30 Cases. World J Surg 2018; 42, 3616-3623.

Article  PubMed  Google Scholar 

Cancer Genome Atlas Research, N. Integrated genomic characterization of papillary thyroid carcinoma. Cell 2014 Oct 23;159(3):676–90.

Oh EJ, Lee S, Bae JS, Kim Y, Jeon S, Jung CK TERT Promoter Mutation in an Aggressive Cribriform Morular Variant of Papillary Thyroid Carcinoma. Endocr Pathol 2017 Mar;28(1):49-53.

Article  CAS  PubMed  Google Scholar 

Bishop JA, Teruya-Feldstein J, Westra WH, Pelosi G, Travis WD, Rekhtman N p40 (DeltaNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. Mod Pathol 2012 Mar;25(3):405-15.

Article  CAS  PubMed  Google Scholar 

Volkel C, De Wispelaere N, Weidemann S, Gorbokon N, Lennartz M, Luebke AM, Hube-Magg C, Kluth M, Fraune C, Moller K, Bernreuther C, Lebok P, Clauditz TS, Jacobsen F, Sauter G, Uhlig R, Wilczak W, Steurer S, Minner S, Krech RH, Dum D, Krech T, Marx AH, Simon R, Burandt E, Menz A Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implications. Virchows Arch 2022 Feb;480(2):433-447.

Article  PubMed  Google Scholar 

Zhu J, Wu K, Lin Z, Bai S, Wu J, Li P, Xue H, Du J, Shen B, Wang H, Liu Y Identification of susceptibility gene mutations associated with the pathogenesis of familial nonmedullary thyroid cancer. Mol Genet Genomic Med 2019 Dec;7(12):e1015.

Article  CAS  PubMed  PubMed Central  Google Scholar 

von Loga K, Kohlhaussen J, Burkhardt L, Simon R, Steuerer S, Burdak-Rothkamm S, Jacobsen F, Sauter G, Krech T FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma. PLoS One 2015 Nov 10;10(11):e0141867.

Article  Google Scholar 

Willis O, Choucair K, Alloghbi A, Stanbery L, Mowat R, Charles BF, Dworkin L, Nemunaitis J PIK3CA gene aberrancy and role in targeted therapy of solid malignancies. Cancer gene therapy 2020 Sep;27(9):634-644.

Article  CAS  PubMed  Google Scholar 

Alqahtani A, Ayesh HSK, Halawani H PIK3CA Gene Mutations in Solid Malignancies: Association with Clinicopathological Parameters and Prognosis. Cancers (Basel) 2019 Dec 30;12(1):93.

Article  PubMed  Google Scholar 

Nikiforov YE, Nikiforova MN Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol 2011 Aug 30;7(10):569-80.

Article  CAS  PubMed  Google Scholar 

Dettmer MS, Schmitt A, Komminoth P, Perren A Poorly differentiated thyroid carcinoma : An underdiagnosed entity. Pathologe 2020 Jun;41(Suppl 1):1-8.

Article  CAS  PubMed  Google Scholar 

Cameselle-Teijeiro JM, Peteiro-Gonzales D, Caneiro-Gomez J, Sanchez-Ares M, Abdulkader I, Eloy C, Melo M, Amendoeira I, Soares P, Sobrinho-Simoes M Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT/beta-catenin pathway. Mod Pathol 2018 Aug;31(8):1168-1179.

Article  CAS  PubMed  Google Scholar 

Tahara I, Oishi N, Mochizuki K, Oyama T, Miyata K, Miyauchi A, Hirokawa M, Katoh R, Kondo T Identification of Recurrent TERT Promoter Mutations in Intrathyroid Thymic Carcinomas. Endocr Pathol 2020 Sep;31(3):274-282.

Article  CAS  PubMed  Google Scholar 

Dettmer MS, Schmitt A, Steinert H, Capper D, Moch H, Komminoth P, Perren A Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT. Endocr Relat Cancer 2015 Jun;22(3):419-29.

Article  CAS  PubMed  Google Scholar 

Liu R, Xing M TERT promoter mutations in thyroid cancer. Endocr Relat Cancer 2016 Mar;23(3):R143-55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kusum L Sharma RBS, Nisreen F, Ricardo VL Cribriform-morular variant of papillary thyroid carcinoma with poorly differentiated features: report of a case and review of the literature. Surg Exp Pathol 2022; 5, 1.

Article  Google Scholar 

Dettmer M, Schmitt A, Steinert H, Haldemann A, Meili A, Moch H, Komminoth P, Perren A Poorly differentiated thyroid carcinomas: how much poorly differentiated is needed? Am J Surg Pathol 2011 Dec;35(12):1866-72.

Article  PubMed  Google Scholar 

Dettmer M, Schmitt A, Steinert H, Moch H, Komminoth P, Perren A Poorly differentiated oncocytic thyroid carcinoma--diagnostic implications and outcome. Histopathology 2012 Jun;60(7):1045-51.

Article  PubMed  Google Scholar 

Volante M, Collini P, Nikiforov YE, Sakamoto A, Kakudo K, Katoh R, Lloyd RV, LiVolsi VA, Papotti M, Sobrinho-Simoes M, Bussolati G, Rosai J Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 2007 Aug;31(8):1256-64.

Article  PubMed  Google Scholar 

Rivera M, Ricarte-Filho J, Patel S, Tuttle M, Shaha A, Shah JP, Fagin JA, Ghossein RA Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate/tumor necrosis): a clinicopathologic and molecular study. Hum Pathol 2010 Feb;41(2):172-80.

Article  CAS  PubMed  Google Scholar 

Patel KN, Yip L, Lubitz CC, Grubbs EG, Miller BS, Shen W, Angelos P, Chen H, Doherty GM, Fahey TJ 3rd, Kebebew E, Livolsi VA, Perrier ND, Sipos JA, Sosa JA, Steward D, Tufano RP, McHenry CR, Carty SE The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults. Ann Surg 2020 Mar;271(3):e21-e93.

Article  PubMed  Google Scholar 

Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016 Jan;26(1):1-133.

Article  PubMed  PubMed Central  Google Scholar 

Dralle H, Musholt TJ, Schabram J, Steinmuller T, Frilling A, Simon D, Goretzki PE, Niederle B, Scheuba C, Clerici T, Hermann M, Kussmann J, Lorenz K, Nies C, Schabram P, Trupka A, Zielke A, Karges W, Luster M, Schmid KW, Vordermark D, Schmoll HJ, Muhlenberg R, Schober O, Rimmele H, Machens A German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors. Langenbecks Arch Surg 2013 Mar;398(3):347-75.

Article  PubMed  Google Scholar